Moxeza FDA Approval History
FDA Approved: Yes (First approved November 19, 2010)
Brand name: Moxeza
Generic name: moxifloxacin
Dosage form: Ophthalmic Solution
Company: Alcon, Inc.
Treatment for: Conjunctivitis, Bacterial
Moxeza (moxifloxacin hydrochloride ophthalmic solution) is a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis.
Development Timeline for Moxeza
|Nov 19, 2010||FDA Approves Moxeza for Bacterial Conjunctivitis|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.